{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T12:52:10Z","timestamp":1792327930491,"version":"4.4.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2013,1,7]],"date-time":"2013-01-07T00:00:00Z","timestamp":1357516800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1038\/npp.2013.4","type":"journal-article","created":{"date-parts":[[2013,1,9]],"date-time":"2013-01-09T13:34:26Z","timestamp":1357738466000},"page":"1060-1067","source":"Crossref","is-referenced-by-count":63,"title":["Modulation of Hippocampal Synaptic Transmission by the Kynurenine Pathway Member Xanthurenic Acid and Other VGLUT Inhibitors"],"prefix":"10.1038","volume":"38","author":[{"given":"S A","family":"Neale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C S","family":"Copeland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V N","family":"Uebele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F J","family":"Thomson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T E","family":"Salt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,1,7]]},"reference":[{"key":"BFnpp20134_CR1","doi-asserted-by":"publisher","first-page":"4358","DOI":"10.1016\/j.bmcl.2011.05.018","volume":"21","author":"SK Ahmed","year":"2011","unstructured":"Ahmed SK, Etoga JL, Patel SA, Bridges RJ, Thompson CM (2011). Use of the hydantoin isostere to produce inhibitors showing selectivity toward the vesicular glutamate transporter versus the obligate exchange transporter system x(c)(-). Bioorg Med Chem Lett 21: 4358\u20134362.","journal-title":"Bioorg Med Chem Lett"},{"key":"BFnpp20134_CR2","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/S0028-3908(98)00080-X","volume":"37","author":"RD Bartlett","year":"1998","unstructured":"Bartlett RD, Esslinger CS, Thompson CM, Bridges RJ (1998). Substituted quinolines as inhibitors of L-glutamate transport into synaptic vesicles. Neuropharmacology 37: 839\u2013846.","journal-title":"Neuropharmacology"},{"key":"BFnpp20134_CR3","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/j.1471-4159.1961.tb13512.x","volume":"7","author":"CA Benassi","year":"1961","unstructured":"Benassi CA, Benassi P, Allegri G, Ballarin P (1961). Tryptophan metabolism in schizophrenic patients. J Neurochem 7: 264\u2013270.","journal-title":"J Neurochem"},{"key":"BFnpp20134_CR4","doi-asserted-by":"publisher","first-page":"3336","DOI":"10.1152\/jn.1998.80.6.3336","volume":"80","author":"AJ Berger","year":"1998","unstructured":"Berger AJ, Dieudonne S, Ascher P (1998). Glycine uptake governs glycine site occupancy at NMDA receptors of excitatory synapses. J Neurophysiol 80: 3336\u20133340.","journal-title":"J Neurophysiol"},{"key":"BFnpp20134_CR5","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1021\/jm010261z","volume":"45","author":"CN Carrigan","year":"2002","unstructured":"Carrigan CN, Bartlett RD, Esslinger CS, Cybulski KA, Tongcharoensirikul P, Bridges RJ et al (2002). Synthesis and in vitro pharmacology of substituted quinoline-2,4-dicarboxylic acids as inhibitors of vesicular glutamate transport. J Med Chem 45: 2260\u20132276.","journal-title":"J Med Chem"},{"key":"BFnpp20134_CR6","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1126\/science.1359647","volume":"258","author":"JD Clements","year":"1992","unstructured":"Clements JD, Lester RA, Tong G, Jahr CE, Westbrook GL (1992). The time course of glutamate in the synaptic cleft. Science 258: 1498\u20131501.","journal-title":"Science"},{"key":"BFnpp20134_CR7","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.neuropharm.2012.03.009","volume":"66","author":"CS Copeland","year":"2013","unstructured":"Copeland CS, Neale SA, Salt TE (2013). Actions of xanthurenic acid, a putative endogenous Group II metabotropic glutamate receptor agonist, on sensory transmission in the thalamus. Neuropharmacology 66: 133\u2013142.","journal-title":"Neuropharmacology"},{"key":"BFnpp20134_CR8","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1113\/jphysiol.2011.218065","volume":"590","author":"CS Copeland","year":"2012","unstructured":"Copeland CS, Neale SA, Salt TE (2012). Positive allosteric modulation reveals a specific role for mGlu2 receptors in sensory processing in the thalamus. J Physiol 590: 937\u2013951.","journal-title":"J Physiol"},{"key":"BFnpp20134_CR9","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1196\/annals.1300.020","volume":"1003","author":"JT Coyle","year":"2003","unstructured":"Coyle JT, Tsai G, Goff D (2003). Converging evidence of NMDA receptor hypofunction in the pathophysiology of schizophrenia. Ann NY Acad Sci 1003: 318\u2013327.","journal-title":"Ann NY Acad Sci"},{"key":"BFnpp20134_CR10","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.schres.2004.05.010","volume":"73","author":"SL Eastwood","year":"2005","unstructured":"Eastwood SL, Harrison PJ (2005). Decreased expression of vesicular glutamate transporter 1 and complexin II mRNAs in schizophrenia: further evidence for a synaptic pathology affecting glutamate neurons. Schizophr Res 73: 159\u2013172.","journal-title":"Schizophr Res"},{"key":"BFnpp20134_CR11","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/S0304-3940(01)02242-X","volume":"313","author":"S Erhardt","year":"2001","unstructured":"Erhardt S, Blennow K, Nordin C, Skogh E, Lindstrom LH, Engberg G (2001). Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia. Neurosci Lett 313: 96\u201398.","journal-title":"Neurosci Lett"},{"issue":"Suppl 1","key":"BFnpp20134_CR12","first-page":"19","volume":"9","author":"F Fazio","year":"2012","unstructured":"Fazio F, Molinaro G, Iacovelli L, Bernabucci M, Mauro G, Di Menna L et al (2012). Xanthurenic acid as a novel putative agonist of Group II metabotropic glutamate receptors. Curr Neuropharmacol 9 (Suppl 1): 19.","journal-title":"Curr Neuropharmacol"},{"key":"BFnpp20134_CR13","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1016\/j.neuropharm.2011.06.007","volume":"62","author":"MJ Fell","year":"2011","unstructured":"Fell MJ, McKinzie DL, Monn JA, Svensson KA (2011). Group II metabotropic glutamate receptor agonists and positive allosteric modulators as novel treatments for schizophrenia. Neuropharmacology 62: 1473\u20131483.","journal-title":"Neuropharmacology"},{"key":"BFnpp20134_CR14","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1126\/science.1097468","volume":"304","author":"RT Fremeau","year":"2004","unstructured":"Fremeau RT, Kam K, Qureshi T, Johnson J, Copenhagen DR, Storm-Mathisen J et al (2004). Vesicular glutamate transporters 1 and 2 target to functionally distinct synaptic release sites. Science 304: 1815\u20131819.","journal-title":"Science"},{"key":"BFnpp20134_CR15","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1124\/jpet.106.102046","volume":"318","author":"R Galici","year":"2006","unstructured":"Galici R, Jones CK, Hemstapat K, Nong Y, Echemendia NG, Williams LC et al (2006). Biphenyl-indanone A, a positive allosteric modulator of the metabotropic glutamate receptor subtype 2, has antipsychotic- and anxiolytic-like effects in mice. J Pharmacol Exp Ther 318: 173\u2013185.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFnpp20134_CR16","doi-asserted-by":"publisher","first-page":"6879","DOI":"10.1523\/JNEUROSCI.15-10-06879.1995","volume":"15","author":"RW Gereau","year":"1995","unstructured":"Gereau RW, Conn PJ (1995). Multiple presynaptic metabotropic glutamate receptors modulate excitatory and inhibitory synaptic transmission in hippocampal area CA1. J Neurosci 15: 6879\u20136889.","journal-title":"J Neurosci"},{"key":"BFnpp20134_CR17","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1111\/j.1471-4159.2008.05219.x","volume":"105","author":"S Gobaille","year":"2008","unstructured":"Gobaille S, Kemmel V, Brumaru D, Dugave C, Aunis D, Maitre M (2008). Xanthurenic acid distribution, transport, accumulation and release in the rat brain. J Neurochem 105: 982\u2013993.","journal-title":"J Neurochem"},{"key":"BFnpp20134_CR18","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/nature06612","volume":"452","author":"J Gonzalez-Maeso","year":"2008","unstructured":"Gonzalez-Maeso J, Ang RL, Yuen T, Chan P, Weisstaub NV, Lopez-Gimenez JF et al (2008). Identification of a serotonin\/glutamate receptor complex implicated in psychosis. Nature 452: 93\u201397.","journal-title":"Nature"},{"key":"BFnpp20134_CR19","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1038\/nm1418","volume":"12","author":"CG Hahn","year":"2006","unstructured":"Hahn CG, Wang HY, Cho DS, Talbot K, Gur RE, Berrettini WH et al (2006). Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia. Nat Med 12: 824\u2013828.","journal-title":"Nat Med"},{"key":"BFnpp20134_CR20","doi-asserted-by":"publisher","first-page":"9736","DOI":"10.1523\/JNEUROSCI.3009-07.2007","volume":"27","author":"MA Herman","year":"2007","unstructured":"Herman MA, Jahr CE (2007). Extracellular glutamate concentration in hippocampal slice. J Neurosci 27: 9736\u20139741.","journal-title":"J Neurosci"},{"key":"BFnpp20134_CR21","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1111\/j.1471-4159.2006.04144.x","volume":"99","author":"E Herzog","year":"2006","unstructured":"Herzog E, Takamori S, Jahn R, Brose N, Wojcik SM (2006). Synaptic and vesicular co-localization of the glutamate transporters VGLUT1 and VGLUT2 in the mouse hippocampus. J Neurochem 99: 1011\u20131018.","journal-title":"J Neurochem"},{"key":"BFnpp20134_CR22","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1006\/phrs.1998.0362","volume":"38","author":"SO Heyliger","year":"1998","unstructured":"Heyliger SO, Goodman CB, Ngong JM, Soliman KF (1998). The analgesic effects of tryptophan and its metabolites in the rat. Pharmacol Res 38: 243\u2013250.","journal-title":"Pharmacol Res"},{"key":"BFnpp20134_CR23","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/371603a0","volume":"371","author":"H Kamiya","year":"1994","unstructured":"Kamiya H, Zucker RS (1994). Residual Ca2+ and short-term synaptic plasticity. Nature 371: 603\u2013606.","journal-title":"Nature"},{"key":"BFnpp20134_CR24","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/S0028-3908(02)00084-9","volume":"43","author":"JN Kew","year":"2002","unstructured":"Kew JN, Pflimlin MC, Kemp JA, Mutel V (2002). Differential regulation of synaptic transmission by mGlu2 and mGlu3 at the perforant path inputs to the dentate gyrus and CA1 revealed in mGlu2-\/- mice. Neuropharmacology 43: 215\u2013221.","journal-title":"Neuropharmacology"},{"key":"BFnpp20134_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0028-3908(97)00191-3","volume":"37","author":"AE Kingston","year":"1998","unstructured":"Kingston AE, Ornstein PL, Wright RA, Johnson BG, Mayne NG, Burnett JP et al (1998). LY341495 is a nanomolar potent and selective antagonist of group II metabotropic glutamate receptors. Neuropharmacology 37: 1\u201312.","journal-title":"Neuropharmacology"},{"key":"BFnpp20134_CR26","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1001\/archpsyc.1994.03950030035004","volume":"51","author":"JH Krystal","year":"1994","unstructured":"Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD et al (1994). Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 51: 199\u2013214.","journal-title":"Arch Gen Psychiatry"},{"key":"BFnpp20134_CR27","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0031-6989(78)80065-4","volume":"10","author":"IP Lapin","year":"1978","unstructured":"Lapin IP (1978a). Convulsions and tremor in immature rats after intraperitoneal injection of kynurenine and its metabolites. Pharmacol Res Commun 10: 81\u201384.","journal-title":"Pharmacol Res Commun"},{"key":"BFnpp20134_CR28","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/BF01262727","volume":"42","author":"IP Lapin","year":"1978","unstructured":"Lapin IP (1978b). Stimulant and convulsive effects of kynurenines injected into brain ventricles in mice. J Neural Transm 42: 37\u201343.","journal-title":"J Neural Transm"},{"key":"BFnpp20134_CR29","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/S0140-6736(69)91140-4","volume":"1","author":"IP Lapin","year":"1969","unstructured":"Lapin IP, Oxenkrug GF (1969). Intensification of the central serotoninergic processes as a possible determinant of the thymoleptic effect. Lancet 1: 132\u2013136.","journal-title":"Lancet"},{"key":"BFnpp20134_CR30","doi-asserted-by":"publisher","first-page":"3798","DOI":"10.1152\/jn.1996.76.6.3798","volume":"76","author":"TA Macek","year":"1996","unstructured":"Macek TA, Winder DG, Gereau RW, Ladd CO, Conn PJ (1996). Differential involvement of group II and group III mGluRs as autoreceptors at lateral and medial perforant path synapses. J Neurophysiol 76: 3798\u20133806.","journal-title":"J Neurophysiol"},{"key":"BFnpp20134_CR31","doi-asserted-by":"publisher","first-page":"e34053","DOI":"10.1371\/journal.pone.0034053","volume":"7","author":"BJ Maher","year":"2012","unstructured":"Maher BJ, LoTurco JJ (2012). Disrupted-in-schizophrenia (DISC1) functions presynaptically at glutamatergic synapses. PLoS One 7: e34053.","journal-title":"PLoS One"},{"key":"BFnpp20134_CR32","unstructured":"Mauro G, Fazio F, Molinaro G, Iacovelli L, Ngomba R, Di Menna L et al (2010). Xanthurenic acid, as a novel endogenous ligand for metabotropic glutamate receptors. Annual Meeting of the Society for Neuroscience, San Diego, CA."},{"key":"BFnpp20134_CR33","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s00213-005-2199-1","volume":"179","author":"MJ Millan","year":"2005","unstructured":"Millan MJ (2005). N-methyl-d-aspartate receptors as a target for improved antipsychotic agents: novel insights and clinical perspectives. Psychopharmacology (Berl) 179: 30\u201353.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp20134_CR34","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1021\/jm9606756","volume":"40","author":"JA Monn","year":"1997","unstructured":"Monn JA, Valli MJ, Massey SM, Wright RA, Salhoff CR, Johnson BG et al (1997). Design, synthesis, and pharmacological characterization of (+)-2- aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY354740): a potent, selective, and orally active group 2 metabotropic glutamate receptor agonist possessing anticonvulsant and anxiolytic properties. J Med Chem 40: 528\u2013537.","journal-title":"J Med Chem"},{"key":"BFnpp20134_CR35","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1111\/j.1742-4658.2012.08551.x","volume":"279","author":"AM Myint","year":"2012","unstructured":"Myint AM (2012). Kynurenines: from the perspective of major psychiatric disorders. FEBS J 279: 1375\u20131385.","journal-title":"FEBS J"},{"key":"BFnpp20134_CR36","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.biopsych.2007.10.020","volume":"63","author":"A Oni-Orisan","year":"2008","unstructured":"Oni-Orisan A, Kristiansen LV, Haroutunian V, Meador-Woodruff JH, McCullumsmith RE (2008). Altered vesicular glutamate transporter expression in the anterior cingulate cortex in schizophrenia. Biol Psychiatry 63: 766\u2013775.","journal-title":"Biol Psychiatry"},{"key":"BFnpp20134_CR37","doi-asserted-by":"publisher","first-page":"6922","DOI":"10.1016\/j.bmc.2010.06.069","volume":"18","author":"N Pietrancosta","year":"2010","unstructured":"Pietrancosta N, Kessler A, Favre-Besse FC, Triballeau N, Quentin T, Giros B et al (2010). Rose Bengal analogs and vesicular glutamate transporters (VGLUTs). Bioorg Med Chem 18: 6922\u20136933.","journal-title":"Bioorg Med Chem"},{"key":"BFnpp20134_CR38","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1093\/schbul\/sbq165","volume":"37","author":"D Pinault","year":"2011","unstructured":"Pinault D (2011). Dysfunctional thalamus-related networks in schizophrenia. Schizophr Bull 37: 238\u2013243.","journal-title":"Schizophr Bull"},{"key":"BFnpp20134_CR39","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1212\/WNL.9.7.456","volume":"9","author":"J Price","year":"1959","unstructured":"Price J, Brown R, Peters H (1959). Tryptophan metabolism in porphyria, schizophrenia, and a variety of neurologic and psychiatric diseases. Neurology 9: 456\u2013468.","journal-title":"Neurology"},{"key":"BFnpp20134_CR40","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/nrn3257","volume":"13","author":"R Schwarcz","year":"2012","unstructured":"Schwarcz R, Bruno JP, Muchowski PJ, Wu HQ (2012). Kynurenines in the mammalian brain: when physiology meets pathology. Nat Rev Neurosci 13: 465\u2013477.","journal-title":"Nat Rev Neurosci"},{"key":"BFnpp20134_CR41","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1126\/science.2154034","volume":"247","author":"MJ Sheardown","year":"1990","unstructured":"Sheardown MJ, Nielsen EO, Hansen AJ, Jacobsen P, Honore T (1990). 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a neuroprotectant for cerebral ischemia. Science 247: 571\u2013574.","journal-title":"Science"},{"key":"BFnpp20134_CR42","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.brainresrev.2004.04.004","volume":"45","author":"Y Shigeri","year":"2004","unstructured":"Shigeri Y, Seal RP, Shimamoto K (2004). Molecular pharmacology of glutamate transporters, EAATs and VGLUTs. Brain Res Brain Res Rev 45: 250\u2013265.","journal-title":"Brain Res Brain Res Rev"},{"key":"BFnpp20134_CR43","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.neuron.2006.12.013","volume":"53","author":"MC Smear","year":"2007","unstructured":"Smear MC, Tao HW, Staub W, Orger MB, Gosse NJ, Liu Y et al (2007). Vesicular glutamate transport at a central synapse limits the acuity of visual perception in zebrafish. Neuron 53: 65\u201377.","journal-title":"Neuron"},{"key":"BFnpp20134_CR44","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1176\/appi.ajp.158.9.1393","volume":"158","author":"RE Smith","year":"2001","unstructured":"Smith RE, Haroutunian V, Davis KL, Meador-Woodruff JH (2001). Expression of excitatory amino acid transporter transcripts in the thalamus of subjects with schizophrenia. Am J Psychiatry 158: 1393\u20131399.","journal-title":"Am J Psychiatry"},{"key":"BFnpp20134_CR45","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.biopsych.2011.02.022","volume":"70","author":"MS Sodhi","year":"2011","unstructured":"Sodhi MS, Simmons M, McCullumsmith R, Haroutunian V, Meador-Woodruff JH (2011). Glutamatergic gene expression is specifically reduced in thalamocortical projecting relay neurons in schizophrenia. Biol Psychiatry 70: 646\u2013654.","journal-title":"Biol Psychiatry"},{"key":"BFnpp20134_CR46","first-page":"309","volume":"45","author":"TW Stone","year":"1993","unstructured":"Stone TW (1993). Neuropharmacology of quinolinic and kynurenic acids. Pharmacol Rev 45: 309\u2013379.","journal-title":"Pharmacol Rev"},{"key":"BFnpp20134_CR47","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.neures.2006.04.016","volume":"55","author":"S Takamori","year":"2006","unstructured":"Takamori S (2006). VGLUTs: \u2018exciting\u2019 times for glutamatergic research? Neurosci Res 55: 343\u2013351.","journal-title":"Neurosci Res"},{"key":"BFnpp20134_CR48","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.neuron.2012.04.019","volume":"74","author":"CH Tischbirek","year":"2012","unstructured":"Tischbirek CH, Wenzel EM, Zheng F, Huth T, Amato D, Trapp S et al (2012). Use-dependent inhibition of synaptic transmission by the secretion of intravesicularly accumulated antipsychotic drugs. Neuron 74: 830\u2013844.","journal-title":"Neuron"},{"key":"BFnpp20134_CR49","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1111\/j.1399-5618.2009.00752.x","volume":"11","author":"A Uezato","year":"2009","unstructured":"Uezato A, Meador-Woodruff JH, McCullumsmith RE (2009). Vesicular glutamate transporter mRNA expression in the medial temporal lobe in major depressive disorder, bipolar disorder, and schizophrenia. Bipolar Disord 11: 711\u2013725.","journal-title":"Bipolar Disord"},{"key":"BFnpp20134_CR50","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/nrn2774","volume":"11","author":"PJ Uhlhaas","year":"2010","unstructured":"Uhlhaas PJ, Singer W (2010). Abnormal neural oscillations and synchrony in schizophrenia. Nat Rev Neurosci 11: 100\u2013113.","journal-title":"Nat Rev Neurosci"},{"key":"BFnpp20134_CR51","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.jpsychires.2011.10.011","volume":"46","author":"E Varea","year":"2012","unstructured":"Varea E, Guirado R, Gilabert-Juan J, Marti U, Castillo-Gomez E, Blasco-Ibanez JM et al (2012). Expression of PSA-NCAM and synaptic proteins in the amygdala of psychiatric disorder patients. J Psychiatr Res 46: 189\u2013197.","journal-title":"J Psychiatr Res"},{"key":"BFnpp20134_CR52","doi-asserted-by":"publisher","first-page":"7158","DOI":"10.1073\/pnas.0401764101","volume":"101","author":"SM Wojcik","year":"2004","unstructured":"Wojcik SM, Rhee JS, Herzog E, Sigler A, Jahn R, Takamori S et al (2004). An essential role for vesicular glutamate transporter 1 (VGLUT1) in postnatal development and control of quantal size. Proc Natl Acad Sci USA 101: 7158\u20137163.","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/npp20134.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp20134","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp20134.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T23:47:03Z","timestamp":1684453623000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/npp20134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,7]]},"references-count":52,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["BFnpp20134"],"URL":"https:\/\/doi.org\/10.1038\/npp.2013.4","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,7]]}}}